Copy Paste Quotes

Groundbreaking genomic test could spare millions of breast cancer patients chemotherapy

Trial suggests patients with a low test score could be treated with hormone therapy alone with near-identical outcomes

Millions of women with breast cancer could be spared chemotherapy with a groundbreaking genomic test, according to the results of a trial that could transform healthcare guidelines worldwide.

Treatment for breast cancer, the world’s most prevalent form of the disease, involves surgery to remove tumours. Chemotherapy is then usually recommended when doctors believe there is a risk the disease will return.

Continue reading...

May 29, 2026 Breast cancer Cancer Women's health

Need the full article?

Use the dedicated news page for the summary, then jump straight to the original source when you want the complete story.